Wegovy vs. Ozempic: Understanding the Differences for Weight Loss

Key Point 1Wegovy and Ozempic both contain semaglutide but are approved for different primary uses: weight loss and type 2 diabetes, respectively.

Key Point 2Wegovy has a higher maximum dosage (2.4 mg) compared to Ozempic (2.0 mg), reflecting its focus on significant weight reduction.

Key Point 3Both medications work by mimicking the GLP-1 hormone, regulating appetite and blood sugar levels.

Key Point 4Hi Doctor AI offers a convenient way to consult with EU-licensed doctors online to determine if Wegovy or other weight loss treatments are right for you.

What are Wegovy and Ozempic?

Wegovy and Ozempic are both injectable medications developed by Novo Nordisk. The active ingredient in both is semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist. This means it mimics the effects of the natural GLP-1 hormone in your body, which plays a crucial role in regulating blood sugar and appetite. While they share the same active ingredient, they are approved for different primary purposes.

Ozempic is primarily prescribed for managing type 2 diabetes. It helps lower blood sugar levels by stimulating insulin release and reducing glucagon secretion. Wegovy, on the other hand, is specifically approved for chronic weight management in adults with obesity (BMI of 30 or higher) or overweight (BMI of 27 or higher) with at least one weight-related condition, such as high blood pressure, type 2 diabetes, or high cholesterol.

Hi Doctor AI provides telemedicine consultations. All treatments are prescribed by EU-licensed doctors after reviewing your medical history. We do not sell or ship medications—prescriptions can be used at any licensed pharmacy in the EU.

Key Differences: Dosage and Intended Use

The most significant difference between Wegovy and Ozempic lies in their approved dosages. Wegovy has a higher maximum maintenance dose of 2.4 mg per week, while Ozempic's maximum dose is 2.0 mg per week. This difference reflects Wegovy's primary focus on weight loss, requiring a higher dose to achieve significant results. The dosages are carefully titrated by your doctor.

While Ozempic can lead to weight loss as a secondary effect, it is not its primary indication. Wegovy is specifically intended to help individuals with obesity or overweight lose weight and maintain that loss over time. Both medications are administered via subcutaneous injection once weekly.

How Semaglutide Works for Weight Loss

Semaglutide, the active ingredient in both Wegovy and Ozempic, works through several mechanisms to promote weight loss:

• Appetite Regulation: Semaglutide acts on the brain to reduce appetite and increase feelings of fullness, leading to decreased food intake.
• Slowed Gastric Emptying: It slows down the rate at which food leaves the stomach, prolonging the feeling of satiety and further reducing appetite.
• Blood Sugar Control: By improving blood sugar control, semaglutide can also help reduce cravings and prevent overeating.

Clinical trials have demonstrated the effectiveness of semaglutide for weight loss. Studies on Wegovy showed that participants achieved an average weight loss of 15-17% of their initial body weight over 68 weeks when combined with lifestyle modifications such as diet and exercise. Ozempic studies also showed weight loss, although typically less pronounced than with Wegovy due to the lower maximum dosage.

Potential Side Effects and Considerations

Like all medications, Wegovy and Ozempic can cause side effects. Common side effects include nausea, vomiting, diarrhea, constipation, and abdominal pain. These side effects are usually mild to moderate and tend to decrease over time as the body adjusts to the medication. More serious side effects, although rare, can include pancreatitis, gallbladder problems, and kidney issues. It is important to discuss your medical history and any potential risks with your doctor before starting either medication.

Semaglutide medications are not suitable for everyone. They are contraindicated in individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. They should also be used with caution in individuals with a history of pancreatitis or gallbladder disease.

How Hi Doctor AI Helps

Hi Doctor AI offers a convenient and discreet way to access medical consultations for weight management. Our EU-licensed doctors can assess your medical history, evaluate your suitability for Wegovy or other weight loss treatments, and provide you with a valid EU prescription if appropriate. The whole process takes place online, with no video call required. Simply fill out a secure medical questionnaire, and our medical team will review your case. If you are eligible, you'll receive your prescription in less than 24 hours. If a prescription is not appropriate for your case, you will receive a full refund of the consultation fee.

Ready to Get Started?

Take the first step towards achieving your weight loss goals. Get your online consultation with Hi Doctor AI—EU-licensed doctors, 45€ consultation fee.